Potential antineoplastics. 8. Synthesis and pharmacology of 6-methyl-2-thio-5-arylazouracils.
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D001391:Azo Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D013438:Sulfhydryl Compounds / Q000138:chemical synthesis / Q000627:therapeutic use; D014498:Uracil / Q000138:chemical synthesis* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001391:Azo Compounds; D013438:Sulfhydryl Compounds; D014498:Uracil